ECSP034469A - Compuesto farmaceutico novedoso - Google Patents

Compuesto farmaceutico novedoso

Info

Publication number
ECSP034469A
ECSP034469A EC2003004469A ECSP034469A ECSP034469A EC SP034469 A ECSP034469 A EC SP034469A EC 2003004469 A EC2003004469 A EC 2003004469A EC SP034469 A ECSP034469 A EC SP034469A EC SP034469 A ECSP034469 A EC SP034469A
Authority
EC
Ecuador
Prior art keywords
compound
pharmaceutical compound
new pharmaceutical
thiazolidin
dione
Prior art date
Application number
EC2003004469A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Donald Colin Mackenzie
Bernadette Marie Choudary
Deirdre O'keeffe
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ECSP034469A publication Critical patent/ECSP034469A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Un novedoso compuesto farmacéuticos( -) Tartrato de 5-(4-(2-N-metil-N-(2-piridil)amino)etoxi)bencil)tiazolidin-2,4-diona o un solvato del mismo, un procedimiento para preparar dicho compuesto, una composición farmacéutica que comprende dicho compuesto y el uso de dicho compuesto en medicina.
EC2003004469A 2000-08-04 2003-02-04 Compuesto farmaceutico novedoso ECSP034469A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019228.6A GB0019228D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ECSP034469A true ECSP034469A (es) 2003-06-25

Family

ID=9897030

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004469A ECSP034469A (es) 2000-08-04 2003-02-04 Compuesto farmaceutico novedoso

Country Status (36)

Country Link
US (1) US20040048899A1 (es)
EP (1) EP1305312B1 (es)
JP (1) JP2004505972A (es)
KR (1) KR100755173B1 (es)
CN (1) CN1458931A (es)
AP (1) AP1814A (es)
AT (1) ATE393153T1 (es)
AU (1) AU2001276509A1 (es)
BG (1) BG107606A (es)
BR (1) BR0112981A (es)
CA (1) CA2417829A1 (es)
CZ (1) CZ2003316A3 (es)
DE (1) DE60133746T2 (es)
DK (1) DK1305312T3 (es)
DZ (1) DZ3467A1 (es)
EA (1) EA004764B1 (es)
EC (1) ECSP034469A (es)
ES (1) ES2302506T3 (es)
GB (1) GB0019228D0 (es)
HK (1) HK1057359A1 (es)
HR (1) HRP20030070A2 (es)
HU (1) HUP0300777A3 (es)
IL (2) IL154278A0 (es)
MA (1) MA25898A1 (es)
MX (1) MXPA03001087A (es)
NO (1) NO324595B1 (es)
NZ (1) NZ524032A (es)
OA (1) OA12352A (es)
PL (1) PL360703A1 (es)
PT (1) PT1305312E (es)
SI (1) SI1305312T1 (es)
SK (1) SK1442003A3 (es)
UA (1) UA76721C2 (es)
WO (1) WO2002012234A1 (es)
YU (1) YU16303A (es)
ZA (1) ZA200300963B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
MY144177A (en) * 2004-02-04 2011-08-15 Novartis Ag Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide.
BRPI0512245A (pt) * 2004-06-30 2008-02-19 Lilly Co Eli composto, composição farmacêutica, e, uso do composto
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
BR0112981A (pt) 2003-08-26
NO20030507D0 (no) 2003-01-31
AP2003002738A0 (en) 2003-03-31
WO2002012234A1 (en) 2002-02-14
YU16303A (sh) 2006-01-16
HUP0300777A2 (hu) 2003-11-28
AU2001276509A1 (en) 2002-02-18
MA25898A1 (fr) 2003-10-01
EP1305312B1 (en) 2008-04-23
IL154278A0 (en) 2003-09-17
ES2302506T3 (es) 2008-07-16
PT1305312E (pt) 2008-06-19
JP2004505972A (ja) 2004-02-26
DE60133746D1 (de) 2008-06-05
KR20030022357A (ko) 2003-03-15
NO20030507L (no) 2003-03-26
GB0019228D0 (en) 2000-09-27
CA2417829A1 (en) 2002-02-14
AP1814A (en) 2008-01-04
KR100755173B1 (ko) 2007-09-03
PL360703A1 (en) 2004-09-20
OA12352A (en) 2006-05-16
ZA200300963B (en) 2004-04-19
DK1305312T3 (da) 2008-07-28
EA200300234A1 (ru) 2003-06-26
HRP20030070A2 (en) 2005-02-28
HK1057359A1 (en) 2004-04-02
NZ524032A (en) 2004-07-30
HUP0300777A3 (en) 2005-04-28
CN1458931A (zh) 2003-11-26
ATE393153T1 (de) 2008-05-15
EP1305312A1 (en) 2003-05-02
DE60133746T2 (de) 2009-05-14
DZ3467A1 (fr) 2002-02-14
EA004764B1 (ru) 2004-08-26
SI1305312T1 (sl) 2008-08-31
SK1442003A3 (en) 2004-05-04
CZ2003316A3 (en) 2004-03-17
US20040048899A1 (en) 2004-03-11
BG107606A (bg) 2003-09-30
NO324595B1 (no) 2007-11-26
UA76721C2 (uk) 2006-09-15
IL154278A (en) 2009-02-11
MXPA03001087A (es) 2003-05-27

Similar Documents

Publication Publication Date Title
HRP20020416B1 (en) Novel composition and use
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
ECSP034469A (es) Compuesto farmaceutico novedoso
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
CY1105903T1 (el) Ενα παραγωγο της θειαζολιδενεδιονης και η χρηση του σαν αντιδιαβητικο
ECSP034468A (es) Compuesto farmaceutico novedoso
RS50136B (sr) Derivati tiazolidindiona i njihova upotreba kao antidijabetika
ECSP034467A (es) Farmaceutico novedoso
ECSP034466A (es) Farmaceutico novedoso
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
ECSP034528A (es) Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona
ECSP003434A (es) Nuevos compuestos
ECSP003435A (es) Nuevos compuestos
ECSP003438A (es) Nuevos compuestos